Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$927M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$430M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$382M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$507M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$430M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$356M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Healthcare | 8.81% |
| 3 | Financials | 8.45% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGO
4751
Calamos Global Total Return Fund
CGO
$130M
| $297K | ﹤0.01% |
18,677
+1,582
| +9% | +$25.8K |
|
4752
Krystal Biotech
KRYS
$9.81B
| $296K | ﹤0.01% |
5,677
+5,472
| +2,669% | +$324K |
|
4753
Tredegar Corp
TG
$292M
| $296K | ﹤0.01% |
24,359
+19,872
| +443% | +$255K |
|
4754
Pulse Biosciences
PLSE
$2.96B
| $295K | ﹤0.01% |
13,655
+3,275
| +32% | +$70.5K |
|
4755
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
| $294K | ﹤0.01% |
4,090
-46,629
| -92% | -$3.4M |
|
4756
InfuSystem Holdings
INFU
$241M
| $291K | ﹤0.01% |
22,301
+7,687
| +53% | +$125K |
|
|
CARM
4757
DELISTED
Carisma Therapeutics
CARM
| $289K | ﹤0.01% |
18,257
+10,826
| +146% | +$520K |
|
|
FORA
4758
DELISTED
Forian
FORA
| $289K | ﹤0.01% |
+27,997
| New | +$311K |
|
|
NEXN
4759
Nexxen International
NEXN
$599M
| $288K | ﹤0.01% |
+15,600
| New | +$325K |
|
|
FNCH
4760
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $288K | ﹤0.01% |
740
+738
| +36,900% | +$315K |
|
4761
HireQuest
HQI
$189M
| $287K | ﹤0.01% |
+14,832
| New | +$285K |
|
4762
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$386M
| $287K | ﹤0.01% |
5,261
-34,269
| -87% | -$1.81M |
|
|
ICAD
4763
DELISTED
iCAD Inc
ICAD
| $286K | ﹤0.01% |
26,520
-4,331
| -14% | -$56.4K |
|
|
FMY
4764
First Trust Mortgage Income Fund
FMY
$49.2M
| $285K | ﹤0.01% |
20,744
-5,433
| -21% | -$75.3K |
|
|
SEVN
4765
Seven Hills Realty Trust
SEVN
$170M
| $284K | ﹤0.01% |
27,577
-1,326
| -5% | -$14.8K |
|
4766
Carter Bankshares
CARE
$703M
| $283K | ﹤0.01% |
19,927
+2,067
| +12% | +$25.5K |
|
4767
PUT
Vale
VALE
$63.4B
| $283K | ﹤0.01% |
+20,300
| New | +$398K |
|
4768
Fresenius Medical Care
FMS
$13B
| $282K | ﹤0.01% |
8,071
+308
| +4% | +$12K |
|
4769
PennantPark Floating Rate Capital
PFLT
$734M
| $282K | ﹤0.01% |
22,072
+3,739
| +20% | +$48.5K |
|
4770
Stoke Therapeutics
STOK
$2.08B
| $282K | ﹤0.01% |
11,075
+6,046
| +120% | +$169K |
|
4771
Impinj
PI
$5.39B
| $281K | ﹤0.01% |
4,917
-4,536
| -48% | -$232K |
|
4772
Cabaletta Bio
CABA
$457M
| $280K | ﹤0.01% |
22,984
+124
| +0.5% | +$1.14K |
|
|
SNP
4773
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $280K | ﹤0.01% |
5,690
-2,917
| -34% | -$139K |
|
4774
Mid Penn Bancorp
MPB
$946M
| $279K | ﹤0.01% |
10,072
-3,036
| -23% | -$81.1K |
|
4775
Invesco Food & Beverage ETF
PBJ
$106M
| $279K | ﹤0.01% |
6,622
-991
| -13% | -$41.4K |
|
Similar funds
Wells Fargo's Q3 2021 Portfolio in Review
As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
- Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
- Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
- Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
- Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
- Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.